Φορτώνει......
Considerations in the development of generic disease therapies for multiple sclerosis
PURPOSE OF REVIEW: Medication prices are a major contributor to the high cost of care for multiple sclerosis (MS). The patents for some of the initial injectable therapies for relapsing MS recently expired, permitting development, regulatory approval, and marketing of generic alternatives with the p...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Neurol Clin Pract |
|---|---|
| Κύριοι συγγραφείς: | , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Lippincott Williams & Wilkins
2016
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4987120/ https://ncbi.nlm.nih.gov/pubmed/27574572 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/CPJ.0000000000000267 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|